Background-The coronary sinus (CS) has a myocardial coat (CSMC) with extensive connections to the left and right atria. We postulated that some posteroseptal and left posterior accessory pathways (CSAPs) result from connections between a cuff of CSMC extending along the middle cardiac vein (MCV) or posterior coronary vein (PCV) and the ventricle. The purpose of the present study was to use CS angiography and mapping to define and determine the incidence of CSAPs and determine the relationship to CS anatomy. Methods and Results-CSAP was defined by accessory pathway (AP) potential or earliest activation in the MCV or PCV and late activation at anular endocardial sites. A CSAP was identified in 171 of 480 patients undergoing ablation of a posteroseptal or left posterior AP. CS angiography revealed a CS diverticulum in 36 (21%) and fusiform or bulbous enlargement of the small cardiac vein, MCV, or CS in 15 (9%) patients. The remaining 120 (70%) patients had an angiographically normal CS. A CSMC extension potential (CSE), like an AP potential, was recorded in the MCV in 98 (82%), in the PCV in 13 (11%), in both the MCV and PCV in 6 (5%), and in the CS in 3 (2%) of 120 patients. CSMC potentials were recorded between the timing of atrial and CSE potentials. Conclusions-CSAPs result from a connection between a CSMC extension (along the MCV or PCV) and the ventricle.
C oronary sinus (CS) diverticula [1] [2] [3] [4] [5] have been associated with posteroseptal and left posterior accessory pathways. These diverticula contain myocardial fibers that connect to both the ventricle and the CS myocardial coat. 1, 2 The CS myocardial coat, present in all individuals, 6 is anatomically 6 -9 and electrically 10 connected to both atria, completing the accessory connection.
We hypothesized that a connection between the CS myocardial coat and the ventricle could produce an accessory pathway (CSAP) in the absence of a diverticulum ( Figure 1 ). In an anatomic study of 240 human hearts, von Ludinghausen and coworkers 6 found sleeve-like extensions of the CS myocardial coat covering the terminal portion of the middle cardiac vein (MCV) and posterior coronary vein (PCV) in 3% and 2% of hearts, respectively (CS myocardial extensions [CSE] , Figure 1 ). They also found myocardial cords extending around the atrioventricular (AV) groove branch of the distal left circumflex coronary artery in 6% of hearts. These myocardial sleeves or cords could serve as a connection between the ventricle and the CS myocardial coat, forming a CSAP. Such a connection could explain a complex of unusual observations found in some patients with posteroseptal or left posterior accessory pathways, including the recording of earliest endocardial antegrade ventricular activation (rapid downstroke on the unfiltered unipolar electrogram) at least 15 ms after the onset of the far-field ventricular potential and at a site 1 to 3 cm apical to the mitral and tricuspid anuli; an oblique course with the ventricular end of the accessory pathway oriented toward the septum (and MCV) and atrial end oriented laterally, consistent with the oblique orientation of the fibers connecting the CS myocardial coat with the left atrium; 6 -9 and attempts to ablate these pathways at the site of earliest retrograde atrial activation often producing a shift in the site of earliest atrial activation (mimicking multiple pathways) consistent with the extensive connections between the CS myocardial coat and the atria.
The purpose of the present study was to use CS angiography and mapping of the CS and its tributaries to identify electrophysiological criteria for CSAP and to determine the incidence and relationship between CSAPs and anatomy of the CS and its branches, including diverticula.
Methods

Study Population
The study population consisted of 480 consecutive patients referred for catheter ablation of a posteroseptal or left posterior accessory pathway.
Electrophysiological Study and CS Angiography
Electrophysiological study was performed as previously described under sedation (fentanyl and midazolam) or general anesthesia (propofol). [11] [12] [13] Retrograde CS angiography was performed in all patients suspected of having a CSAP on the basis of the presence of a negative delta wave in ECG lead II 14 or mapping results from the present or previous electrophysiological study. Before 1994, CS angiography was performed using an 8F guiding catheter and rapid injection of 20 mL of contrast media. Visualization of individual veins or a CS diverticulum required selective injection. In 1994, a balloon occlusion technique was developed. An angiographic catheter with a compliant balloon located close to the tip (Vueport, Cardima) was inserted into the CS and great cardiac vein. The balloon was inflated with 0.5 to 1.5 mL of air to occlude the great cardiac vein. Contrast media (5 to 15 mL) was slowly injected, filling the venous system distal to the balloon. Flow through collaterals resulted in antegrade filling of the MCV, PCV, and small cardiac vein (even if the vessel was occluded after a prior ablation procedure). The catheter was slowly withdrawn with the balloon inflated, resulting in retrograde filling of these veins.
Multielectrode catheters were positioned in the right atrial appendage, His bundle region, CS, and right ventricle. An additional catheter was used for mapping the tricuspid anulus, CS, and its branches.
Programmed stimulation of the right atrial appendage, posterolateral CS, anterobasal right ventricular septum (para-Hisian pacing), 12 and posterobasal ventricular septum (close to the accessory pathway) 13 was performed, verifying the presence of a posteroseptal or left posterior accessory pathway. Mapping of the tricuspid anulus, CS, and venous branches, and in selected patients, the mitral anulus (transseptal or retrograde transaortic approach) was performed during antegrade and retrograde accessory pathway conduction. Filtered (30 to 500 Hz) bipolar and unfiltered (1 to 500 Hz) unipolar electrograms were recorded simultaneously from the mapping catheter. Because of the oblique course in these accessory pathways (atrial end oriented leftward), atrial pacing for mapping during antegrade accessory pathway conduction was performed from the right atrial appendage to provide greater separation between the atrial, CS myocardial coat, and ventricular potentials in the CS electrograms. 13 For mapping during retrograde accessory pathway conduction, pacing was often performed at the basal posterolateral left ventricle from a posterior or lateral coronary vein (PCV catheter in Figure 2A ) to provide greater separation between the ventricular and atrial potentials in the CS electrograms. 13 
Definition of CSAP
A posteroseptal or left posterior accessory pathway was identified as a CSAP when meeting the following criteria.
During Antegrade Accessory Pathway Conduction
The earliest endocardial ventricular activation (rapid downstroke on the unfiltered unipolar electrogram, local V, Figure 2 ) was recorded Ն15 ms after the onset of the far-field ventricular potential at a site located Ն1 cm apical to the tricuspid and mitral anuli. Ventricular activation recorded from the MCV, PCV, or CS diverticulum preceded endocardial ventricular activation (Figure 2) . A highfrequency potential similar to an antegrade accessory pathway activation potential, 15 presumably generated by an extension of the CS myocardial coat (Figures 1 and 3 ) was recorded from the MCV, PCV, or neck of a CS diverticulum before the earliest far-field ventricular potential, and the antegrade CSE potential was dissociated from local atrial and ventricular activation by the use of ventricular extrastimuli ( Figure 4 ). 15 
During Retrograde Accessory Pathway Conduction
The earliest high-frequency potential (similar to a retrograde AP potential) 15 was recorded from the MCV, PCV, or neck of a CS diverticulum, and was presumably generated by an extension of the CS myocardial coat (CSE in Figure 5 ). The CSE potential was followed by activation of the CS myocardial coat, with the earliest CS myocardial coat potential recorded near the orifice of the vein ( Figure 5A , first complex, CS 1 in electrograms MCV-Bip 3-4 and CS 9 ). The CS myocardial coat potentials propagated leftward ( Figure  5A , CS 1 in electrograms CS 8 to CS 5 ), activating the left atrium before the right atrium (in patients without a prior ablation procedure). Left atrial activation began 1 to 3 cm leftward of the earliest CS myocardial coat potential. Therefore, 2 potentials (CS myocardial coat and left atrial potentials) were recorded in the CS near the orifice of the vein (CS 1 and A 1 in electrograms MCV-Bip 3-4 and CS 8 to CS 9 , Figure 5A ). The retrograde CS myocardial coat potential was then differentiated from the retrograde atrial potential by delivering a late atrial extrastimulus ( Figure 5A ). Earlier atrial extrastimuli differentiated the retrograde CSE potential (recorded in the MCV, PCV, or CS diverticulum) from the CS myocardial coat potential ( Figure 5B ) and the local ventricular potential ( Figure 5C ). 15 
Results
Of
CS Diverticula
Retrograde CS angiography demonstrated a CS diverticulum in 36 (21%) of 171 CSAP patients. The diverticulum extended from the CS in 26 patients ( Figure 6A , 6B, 6E, and 6F), the MCV in 9 ( Figure 6C and 6D) , and both the CS and MCV in 1 patient ( Figure 7C ). Diverticula entered the CS with either a narrow ( Figure 6A ), intermediate ( Figure 6E ), or wide neck ( Figure 6B ). The diverticulum originated within 1.5 cm of the CS ostium (including MCV) in 27 patients ( Figure 6E ) and between 1.5 cm and the insertion of the great cardiac vein into the CS in 9 ( Figure 6F ). The width of the diverticulum (septal-lateral) ranged from 5 to 50 mm (median 18 mm). The diverticula contracted during ventricular systole ( Figures 6C, 6D , 7A, and 7B), eliminating the contrast media within several beats. In 4 patients, the diverticulum had multiple lobes or complex geometry ( Figures 7A through 7C ). Three other patients had 2 diverticula. Both diverticula inserted into the CS in 2 patients ( Figure 7D ). In the third patient, the 2 diverticula inserted into the junction of a large MCV and small collateral vein extending between the MCV and PCV ( Figure 7E and 7F) .
The CSAP was not related to the diverticulum in 2 of 36 patients. The CSAP was associated with the PCV in 1 and a collateral vein between the MCV and PCV in the other. In 2 other patients who each had 2 diverticula, the CSAP was associated with only 1 of the 2 diverticula (D 2 in Figures 7D  through 7F) . Therefore, 4 of the 39 diverticula were not associated with an accessory pathway.
A CSE potential was recorded in the neck (or orifice of the diverticulum into the CS or MCV) in all 35 diverticula (34 patients) associated with a CSAP. The neck was large enough to allow mapping inside the body of 15 diverticula. Fusion of the CSE and earliest ventricular potentials was identified in all 15 and were located at 2 or more sites (multiple ventricular connections) in 6.
Of the 34 patients with a CSAP associated with a diverticulum, conduction occurred in both the antegrade and retrograde directions in 31 (91%) and only in the retrograde direction in 3 (9%). Of 31 patients with preexcitation, the delta wave was negative in lead II in 24 (77%).
Other Anomalies
Other venous anomalies were identified in 15 (9%) of 171 patients with CSAP. CS angiography showed fusiform enlargement of the terminal portion of the small cardiac vein in 3 patients and both the small cardiac vein and MCV in 9 patients ( Figure 8A ). Of these 12 patients, a CSE potential was recorded from the small cardiac vein in 2 and junction of the small cardiac vein and MCV in 8. Access to the MCV or small cardiac vein was unavailable in the remaining 2 patients, related to prior ablation procedures. In 1 patient, the MCV was narrowed at its insertion into the CS. A CSE potential was recorded from the CS at the orifice of the MCV. The second had occlusion of the small cardiac vein at its insertion into the MCV. The CSE potential was not recorded from the MCV or CS.
CS angiography showed a bulbous enlargement of the MCV in 2 patients ( Figure 8B ) and a segment of the CS in 1 patient. A CSE potential was recorded from the bulbous region of the MCV in 1 of 2 patients. In the second, the CSE potential was recorded from the CS, midway between the MCV and PCV. A CSE potential was recorded from the bulbous region of the CS in the single patient with that anomaly.
Of the 14 CSAPs related to venous enlargement, 5 conducted only in the retrograde direction and 1 conducted only in the antegrade direction. In the 9 patients with preexcitation, the delta wave was negative in lead II in 6 (67%).
Normal CS Anatomy
CS angiography demonstrated normal venous anatomy in 120 (70%) of 171 CSAP patients. A CSE potential was recorded between the timing of the CS myocardial coat potential and ventricular potential from the terminal portion of the MCV in 98 (82%), PCV in 13 (11%), both MCV and PCV in 6 (5%), and the floor of the CS between the MCV and PCV in 3 (2%) of the 120 patients. The CSE potential was recorded at various distances (5 to 20 mm) into the MCV or PCV ( Figure  3) . The terminal segment of the MCV and PCV often contracted during atrial systole ( Figures 8C through 8D) , consistent with a cuff of myocardial fibers. This was not a specific finding, however. Systolic contraction was occasionally observed in patients without a CSAP.
The accessory pathway conducted only in the antegrade direction in 1, only in the retrograde direction in 36, and in both directions in 83 of the 120 patients. In the 84 patients with preexcitation, the delta wave was negative in lead II in 57 (68%).
Discussion
One of the primary findings of the present study is that the majority (70%) of CSAPs occur without a diverticulum or other venous anomaly, and the ventricular end is located close to the MCV or PCV. The recording of CS myocardial coat potentials between the timing of the atrial and ventricular potentials during antegrade and retrograde accessory pathway conduction supports the hypothesis that these accessory pathways use the CS myocardial coat as the intermediary between the atria and ventricles. The recording of CSE potentials within the MCV or PCV, between the timing of the CS myocardial coat and ventricular potentials, suggests the CSE potentials are generated by extensions of the CS myocardial coat and supports the hypothesis that the ventricular end of the accessory pathway is formed by a connection between an extension of the CS myocardial coat (along or near the vein) and the epicardial surface of the ventricle (Figure 1 ). This hypothesis is further supported by the systolic contraction of the CS and terminal segment of these veins ( Figure 8C and 8D) . The atrial end of the accessory pathway is formed by connections between the CS myocardial coat and the left and right atria. The oblique course of the inner fibers 6 -9 favors earlier activation of the left atrium, 1 to 3cm leftward of the ventricular connection (Figure 1) . However, in 7 patients with prior ablation in the orifice of the small cardiac vein, MCV, or neck of a CS diverticulum preventing retrograde activation of the CS myocardial coat (and the left atrium), a connection to the right atrium persisted.
CS angiography identified 1 or 2 CS diverticula in 36 patients, 7.5% of 480 patients with any type of posteroseptal or left posterior accessory pathway. These values overestimate the prevalence of diverticula, because 32 of the 36 patients were referred after at least 1 unsuccessful ablation procedure. CS diverticula were present in only 4 (2%) of 201 patients with no prior ablation. The CSAP was related to the diverticulum in 34 of the 36 patients. In those 34 patients, the myocardium in the wall of the diverticulum was connected electrically to the epicardial surface of the ventricle. The diverticular myocardium was connected electrically to the CS myocardial coat through its neck. The body of these diverticula contracted during ventricular systole, consistent with the presence of myocardial fibers.
These 36 patients represent the largest reported series of CS diverticula. Each diverticulum was unique, varying widely in size (5 to 50 mm) and shape. Some had multiple lobes. Most had a discreet neck (narrower than the body of the diverticulum but highly variable in diameter), which extended from any site along the length of the CS from close to the CS ostium to near the insertion of the great cardiac vein, although most were located within 1.5 cm of the CS ostium. In 25%, the diverticulum extended from the MCV rather than the CS. Two adjacent diverticula were present in 3 patients.
The relationship between CSAP and fusiform or bulbous enlargement of the veins is less clear. In an anatomic study of 150 human hearts, bulbous enlargement of the MCV was present in 30%. 16 Bulbous enlargement of the MCV was identified angiographically in the present study in only 2 of 171 CSAP patients, suggesting the angiographic findings may be very subtle. In contrast, we are not aware of any prior description of fusiform dilatation of the small cardiac vein and MCV. The accessory pathway was related to the enlarged region of the small cardiac vein or MCV in all 12 patients, suggesting a significant relationship between fusiform enlargement and CSAP.
Of the 126 CSAP patients with preexcitation, the delta wave was negative in lead II in 88 (70%). The sensitivity of a negative delta wave in lead II in identifying a CSAP in the present study (70%) is lower than found in our previous study. 14 That study, however, included only 14 patients with CSAP.
The extensive connections between the CS myocardial coat and the atria, the oblique course of the CS myocardial fibers, and the lack of a clear endocardial location for the ventricular insertion combine to complicate localization of CSAPs, frequently leading to failure of catheter ablation. In the present study, a CSAP was present in 47% of patients with a posteroseptal or left posterior accessory pathway and a prior failed attempt at ablation, compared with 19% without a prior ablation procedure.
Of the 201 patients with posteroseptal and left posterior accessory pathways and no prior ablation procedure, 81% did not meet the criteria for CSAP. In those patients, retrograde activation of the right or left atrium preceded activation of the CS myocardial coat. Neither earliest antegrade ventricular activation nor a CSE potential was recorded from the MCV or PCV. None had a CS diverticulum and only 2 had fusiform enlargement of the MCV or small cardiac vein. Therefore, as previously described by Becker and coworkers, 17 the majority of accessory pathways in this region do not involve the CS myocardial coat or its extensions. 
